Jeffrey V. Poulton - Feb 13, 2025 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Signature
By: Brett Budzinski, Attorney-in-Fact For: Jeffrey V. Poulton
Stock symbol
ALNY
Transactions as of
Feb 13, 2025
Transactions value $
-$246,750
Form type
4
Date filed
2/18/2025, 04:47 PM
Previous filing
Nov 27, 2024
Next filing
Mar 3, 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALNY Common Stock Award $0 +3.11K +10.15% $0.00 33.8K Feb 13, 2025 Direct F1
transaction ALNY Common Stock Sale -$54.8K -217 -0.64% $252.50 33.5K Feb 14, 2025 Direct F2, F3
transaction ALNY Common Stock Sale -$60.6K -239 -0.71% $253.37 33.3K Feb 14, 2025 Direct F2, F4
transaction ALNY Common Stock Sale -$40.7K -160 -0.48% $254.35 33.1K Feb 14, 2025 Direct F2, F5
transaction ALNY Common Stock Sale -$17.4K -68 -0.21% $255.56 33.1K Feb 14, 2025 Direct F2, F6
transaction ALNY Common Stock Sale -$20K -78 -0.24% $256.29 33K Feb 14, 2025 Direct F2, F7
transaction ALNY Common Stock Sale -$9.53K -37 -0.11% $257.51 33K Feb 14, 2025 Direct F2, F8
transaction ALNY Common Stock Sale -$12.1K -47 -0.14% $258.07 32.9K Feb 14, 2025 Direct F2, F9
transaction ALNY Common Stock Sale -$4.42K -17 -0.05% $259.72 32.9K Feb 14, 2025 Direct F2, F10
transaction ALNY Common Stock Sale -$7.82K -30 -0.09% $260.57 32.9K Feb 14, 2025 Direct F2, F11
transaction ALNY Common Stock Sale -$9.67K -37 -0.11% $261.45 32.8K Feb 14, 2025 Direct F2, F12
transaction ALNY Common Stock Sale -$4.48K -17 -0.05% $263.33 32.8K Feb 14, 2025 Direct F2
transaction ALNY Common Stock Sale -$5.3K -20 -0.06% $264.87 32.8K Feb 14, 2025 Direct F2
holding ALNY Common Stock 57 Feb 13, 2025 by Managed Account F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 24, 2021, the reporting person was granted a performance-based stock unit (PSU) under the 2018 Stock Incentive Plan. The shares subject to the PSU vest based on the achievement of four specified performance measures. The shares reported were issued to the reporting person upon vesting of one-quarter of the shares subject to the PSU based on the issuer publicly reporting achievement, on or before December 31, 2025, of non-GAAP operating income profitability for a 12-month calendar year, as determined by The People, Culture and Compensation Committee of the Issuer Board of Directors on February 13, 2025.
F2 Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of restricted stock units reported in this form.
F3 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $251.89 to $252.89. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F4 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $252.90 to $253.89. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F5 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $253.96 to $254.93. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F6 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $254.99 to $255.97. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F7 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $256.01 to $256.84. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F8 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $257.05 to $257.78. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F9 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $257.86 to $258.44. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F10 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $259.21 to $260.14. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F11 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $260.31 to $260.96. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F12 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $261.42 to $261.47. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F13 Reflects shares of ALNY common stock acquired by the Reporting Person under the issuer 401(k) plan as a result of the issuer 401(k) matching contribution program.